Company Intellicell Biosciences Inc OTC Bulletin Board
Equities
US45825A1051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven A. Victor
CEO | Chief Executive Officer | 71 | 11-06-02 |
Anna Rhodes
PRN | Corporate Officer/Principal | - | 11-06-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven A. Victor
CEO | Chief Executive Officer | 71 | 11-06-02 |
Harold Bafitis
BRD | Director/Board Member | - | - |
Greg Cavaliere
BRD | Director/Board Member | - | - |
Gil Chimes
BRD | Director/Board Member | - | - |
Director/Board Member | - | - | |
Joshua Hackel
BRD | Director/Board Member | - | - |
Frederick Nicola
BRD | Director/Board Member | - | - |
Wilson Tawe
BRD | Director/Board Member | - | - |
Nicholas Toscano
BRD | Director/Board Member | - | - |
Erich Richter
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 56,500 | 0 | 0 | 100.00 % |
Stock B | 0 | 7,250 | 0 | 0 | |
Stock C | 1 | 7,894,037,082 | 7,894,037,082 ( 100.00 %) | 0 | |
Stock D | 0 | 15,057 | 0 | 0 |
Company contact information
Intellicell Biosciences, Inc.
460 Park Avenue 17th floor
10022, New York
+
http://www.intellicellbiosciences.comSector
1st Jan change | Capi. | |
---|---|---|
+34.01% | 51.07B | |
-8.02% | 38.78B | |
+34.86% | 38.86B | |
-11.12% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- Stock
- Stock
- Company Intellicell Biosciences Inc